Global Vitamin D Testing Market 2017-2021

  • ID: 4307461
  • Report
  • Region: Global
  • 85 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diazyme Laboratories
  • F. Hoffmann-La Roche
  • QUALIGEN.
  • Siemens Healthineers
  • MORE
About Vitamin D Testing

Vitamin D is a fat-soluble vitamin that helps in calcium absorption and maintains serum calcium and phosphate concentration to regularize the mineralization of the bone and to prevent hypocalcemic tetany. It plays many roles in the human body such as maintains cell cycle, reduces the chances of neuromuscular disorder and inflammation in joints, and enhances immune function.

The analysts forecast the global vitamin D testing market to grow at a CAGR of 4.61% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global vitamin D testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales, volume and value of vitamin D testing specific assay kits.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Vitamin D Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- F. Hoffmann-La Roche
- Abbott
- Siemens Healthineers

Other prominent vendors
- Biokit
- The Vitamin D Company
- Tosoh Bioscience
- QUALIGEN

Market drivers
- Increase in number of vitamin D deficiency disorders
- For a full, detailed list, view the full report

Market challenges
- Increasing cost burden on patients
- For a full, detailed list, view the full report

Market trends
- Rising number of home-based healthcare services
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key Market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are theKey vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diazyme Laboratories
  • F. Hoffmann-La Roche
  • QUALIGEN.
  • Siemens Healthineers
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global 25-Hydroxy vitamin D testing market
  • Global 1,25-Dihydroxy vitamin D testing market
PART 07: Market segmentation by end-user
  • Diagnostic laboratories
  • Hospitals and physician clinics
  • Home care settings
PART 08: Geographical segmentation
  • Global vitamin D testing market by geography
  • Vitamin D testing market in Americas
  • Vitamin D testing market in EMEA
  • Vitamin D testing market in APAC
PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Increasing partnership and collaboration activities
  • Rising number of home-based healthcare services
PART 11: Vendor landscape
  • Competitive landscape
  • F. Hoffmann-La Roche
  • Abbott
  • Siemens Healthineers
  • Key companies to watch
  • Other Prominent Vendors
  • List of abbreviations
List of Exhibits
Exhibit 01: Overview of global vitamin D testing market
Exhibit 02: Global vitamin D testing market: Impact assessment
Exhibit 03: Scope of global vitamin D testing market in various regions 2017-2021 ($ million)
Exhibit 04: Global vitamin D testing market 2016-2021 ($ million)
Exhibit 05: Focus areas for existing companies and new entrants
Exhibit 06: Opportunity analysis of global vitamin D testing market
Exhibit 07: Five forces analysis
Exhibit 08: Global vitamin D testing market by product 2016-2021 ($ million)
Exhibit 09: Clinical efficacy of Siemens Healthcare, DiaSorin, Abbott, and F. Hoffmann-La Roche
Exhibit 10: Market overview: Global 25-Hydroxy vitamin D testing market
Exhibit 11: Global 25-Hydroxy vitamin D testing market 2016-2021 ($ million)
Exhibit 12: Market overview: Global 1,25-Dihydroxy vitamin D testing market
Exhibit 13: Global 1,25-Dihydroxy vitamin D test market 2016-2021 ($ million)
Exhibit 14: Global vitamin D testing market by end-users 2016
Exhibit 15: Buying criteria for end-users in global vitamin D testing market 2016
Exhibit 16: Buying criteria for end-users: Global vitamin D testing market 2016
Exhibit 17: Global vitamin D testing market by geography 2016-2021 ($ millions)
Exhibit 18: Increasing incidence of diabetes in US (2010 to 2014)
Exhibit 19: Market outlook in Americas
Exhibit 20: Vitamin D testing market in Americas 2016-2021 ($ million)
Exhibit 21: Vitamin D testing market in Americas: Country specific market analysis
Exhibit 22: Opportunity analysis: Vitamin D testing market in US
Exhibit 23: Market outlook in EMEA
Exhibit 24: Vitamin D testing market in EMEA 2016-2021 ($ millions)
Exhibit 25: Vitamin D testing market in EMEA: Country specific market analysis
Exhibit 26: Opportunity analysis: Vitamin D testing market in UK
Exhibit 27: Market outlook for APAC
Exhibit 28: Vitamin D testing market in APAC 2016-2021 ($ million)
Exhibit 29: Vitamin D testing in APAC: Country specific market analysis
Exhibit 30: Opportunity analysis: Vitamin D testing market in India
Exhibit 31: Incidence of obesity in adults in US
Exhibit 32: Trends in increasing prevalence of diabetes in people aged 20-79 (2008-2014)
Exhibit 33: Number of hospital M&A in US in 2010-2015
Exhibit 34: Competitive structure analysis of global vitamin D testing market
Exhibit 35: Competitive strategy for manufacturing companies
Exhibit 36: Competitive landscape analysis of the companies
Exhibit 37: Business strategies for the companies in global vitamin D testing market
Exhibit 38: F. Hoffmann-La Roche: Strength Assessment
Exhibit 39: F. Hoffmann-La Roche: Strategy assessment
Exhibit 40: F. Hoffmann-La Roche: Opportunity Assessment
Exhibit 41: Abbott: Strength assessment
Exhibit 42: Abbott: Strategy Assessment
Exhibit 43: Abbott: Opportunity assessment
Exhibit 44: Siemens Healthineers: Strength assessment
Exhibit 45: Siemens Healthineers: Strategy assessment
Exhibit 46: Siemens Healthineers: Opportunity assessment
Exhibit 47: Key companies to watch: Global vitamin D testing market
Exhibit 48: Other prominent vendors: Global vitamin D testing market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diazyme Laboratories
  • F. Hoffmann-La Roche
  • QUALIGEN.
  • Siemens Healthineers
  • MORE
New Report Released: – Global Vitamin D Testing Market 2017-2021

The author of the report recognizes the following companies as the key players in the global vitamin D testing market: F. Hoffmann-La Roche, Abbott, and Siemens Healthineers.

Other Prominent Vendors in the market are: Diazyme Laboratories, Biokit, The Vitamin D Company, Tosoh Bioscience, and QUALIGEN.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is rising number of home-based healthcare services. Home-based healthcare services have become a trend that increases the demand for vitamin D testing for better compatibility, portability, and user-friendly testing method. The vitamin D blood spot testing kit contain the assay and reagent. Also, it costs much lower than hospitals and diagnostic clinics.”

According to the report, one of the major drivers for this market is increase in number of vitamin d deficiency disorders. Vitamin D is associated with major health disorders such as diabetes, kidney disorder, cancer, nutritional rickets, obesity, heart disease, and orthopedic issue. Worldwide, there is an increase in the number of obesity and diabetes cases. According to OECD, in 2014, 18% of the total adult population and children were obese, especially in countries such as Mexico, New Zealand, the US, Canada, Chile, Australia, and England.

Further, the report states that one of the major factors hindering the growth of this market is increasing cost burden on patients. Many clinical diagnostic laboratories and hospital labs provide low-cost assays in a package that combines many tests. The average cost of vitamin D tests is $20 or less, which is not profitable for most large and medium-sized diagnostic laboratories and hospital labs. Therefore, they combined related tests into healthcare package like master health check-up, which costs patients around $180 to $200. This increases the cost burden on the patients and can affect the market negatively.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • F. Hoffmann-La Roche
  • Abbott
  • Siemens Healthineers
  • Diazyme Laboratories
  • Biokit
  • The Vitamin D Company
  • Tosoh Bioscience
  • QUALIGEN.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll